자궁내막증의 임상진료지침

키워드

참고문헌 (62)

1. Waller KG, "The prevalence of endometriosis in women with infertile partners", Eur J Obstet Gynecol Reprod Biol, 48, pp.135~139 (1993)
2. Fauconnier A, "Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications", Hum Reprod Update, 11, pp.595~606 (2005)
3. Rawson JM, "Prevalence of endometriosis in asymptomatic women", J Reprod Med, 36, pp.513~515 (1991)
4. Damario MA, "Classifi cation of endometriosis", Semin Reprod Endocrinol, 15, pp.235~244 (1997)
5. Chapron C, "Deep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease", Hum Reprod, 18, pp.760~766 (2003)
6. Koninckx PR, "Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain", Fertil Steril, 55, pp.759~765 (1991)
7. Porpora MG, "Correlation between endometriosis and pelvic pain", J Am Assoc Gynecol Laparosc, 6, pp.429~434 (1999)
8. Koninckx PR, "Diagnosis of deep endometriosis by clinical examination during menstruation and plasma CA-125 concentration", Fertil Steril, 65, pp.280~287 (1996)
9. D’Hooghe TM, "Endometriosis and subfertility: is the relationship resolved", Semin Reprod Med, 21, pp.243~254 (2003)
10. Chapron C, "Anatomical distribution of deeply infi ltrating endometriosis: surgical implications and proposition for a classifi cation", Hum Reprod, 18, pp.157~161 (2003)
11. Koninckx PR, "Deeply infi ltrating endometriosis is a disease whereas mild endometriosis could be considered a non-disease", Ann N Y Acad Sci, 734, pp.333~341 (1994)
12. Moore J, "A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis", Ultrasound Obstet Gynecol, 20, pp.630~634 (2002)
13. Mol BW, "The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis", Fertil Steril, 70, pp.1101~1108 (1998)
14. Sutton CJ, "Follow-up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis", Fertil Steril, 68, pp.1070~1074 (1997)
15. Korean Endometriosis Society, "The 13th symposium on endometriosis", pp.151~155 (2011), Korean Endometriosis Society
16. Yap C, "Pre and post operative medical therapy for endometriosis surgery", Cochrane Database Syst Rev, (3), pp.CD003678~ (2004)
17. Lefebvre G, "SOGC clinical guidelines. Hysterectomy", J Obstet Gynaecol Can, 24, pp.37~61 (2002)
18. Namnoum AB, "Incidence of symptom recurrence after hysterectomy for endometriosis", Fertil Steril, 64, pp.898~902 (1995)
19. Crosignani PG, "Laparoscopy versus laparotomy in conservative surgical treatment for severe endometriosis", Fertil Steril, 66, pp.706~711 (1996)
20. Jacobson TZ, "Laparoscopic surgery for pelvic pain associated with endometriosis", Cochrane Database Syst Rev, (4), pp.CD001300~ (2001)
21. Jacobson TZ, "Laparoscopic surgery for subfertility associated with endometriosis", Cochrane Database Syst Rev, (4), pp.CD001398~ (2002)
22. Telimaa S, "Placebocontrolled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis", Gynecol Endocrinol, 1, pp.13~23 (1987)
23. Brown J, "Gonadotrophin-releasing hormone analogues for pain associated with endometriosis", Cochrane Database Syst Rev, (12), pp.CD008475~ (2010)
24. Bayer SR, "Efficacy of danazol treatment for minimal endometriosis in infertile women. A prospective, randomized study", J Reprod Med, 33, pp.179~183 (1988)
25. Fedele L, "Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: a randomized clinical trial", Am J Obstet Gynecol, 166, pp.1345~1350 (1992)
26. Gambone JC, "Chronic Pelvic Pain", Endometriosis Working Group. Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process, 2002, 961~972
27. Dicker D, "The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer", Fertil Steril, 57, pp.597~600 (1992)
28. Surrey ES, "Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis", Fertil Steril, 78, pp.699~704 (2002)
29. Abou-Setta AM, "Levonorgestrelreleasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery", Cochrane Database Syst Rev, (4), pp.CD005072~ (2006)
30. Harada T, "Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial", Fertil Steril, 90, pp.1583~1588 (2008)
31. Vercellini P, "Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen", Fertil Steril, 80, pp.560~563 (2003)
32. Coffee AL, "Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen", Contraception, 75, pp.444~449 (2007)
33. Strowitzki T, "Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial", Hum Reprod, 25, pp.633~641 (2010)
34. Cosson M, "Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study", Fertil Steril, 77, pp.684~692 (2002)
35. Harada T, "Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis: a randomized, double-blind, multicenter, controlled trial", Fertil Steril, 91, pp.675~681 (2009)
36. Köhler G, "A dose-ranging study to determine the effi cacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis", Int J Gynaecol Obstet, 108, pp.21~25 (2010)
37. Strowitzki T, "Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study", Eur J Obstet Gynecol Reprod Biol, 151, pp.193~198 (2010)
38. Petraglia F, "Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment", Arch Gynecol Obstet (2011)
39. Schlaff WD, "Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain", Fertil Steril, 85, pp.314~325 (2006)
40. Crosignani PG, "Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain", Hum Reprod, 21, pp.248~256 (2006)
41. Prentice A, "Gonadotrophin-releasing hormone analogues for pain associated with endometriosis", Cochrane Database Syst Rev, (2), pp.CD000346~ (2000)
42. Sagsveen M, "Gonadotrophinreleasing hormone analogues for endometriosis: bone mineral density", Cochrane Database Syst Rev, (4), pp.CD001297~ (2003)
43. "Treatment of pelvic pain associated with endometriosis", Practice Committee of American Society for Reproductive Medicine, pp.260~269 (2008)
44. Packard CJ, "Action of danazol on plasma lipids and lipoprotein metabolism", Acta Obstet Gynecol Scand Suppl, 159, pp.35~40 (1994)
45. Cottreau CM, "Goodman MT. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer", Clin Cancer Res, 9, pp.5142~5144 (2003)
46. Badawy SZ, "Angiotensin-converting enzyme: a role in reproduction? Questions to be answered", Fertil Steril, 72, pp.749~750 (1999)
47. Petta CA, "Randomized clinical trial of a levonorgestrelreleasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis", Hum Reprod, 20, pp.1993~1998 (2005)
48. Lockhat FB, "The effi cacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up", Hum Reprod, 20, pp.789~793 (2005)
49. Fedele L, "Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis", Fertil Steril, 75, pp.485~488 (2001)
50. Beral V, "Breast cancer and hormone-replacement therapy in the Million Women Study", Lancet, 362, pp.419~427 (2003), Million Women Study Collaborators
51. Giudice LC, "Endometriosis", Lancet, 364, pp.1789~1799 (2004)
52. Bulun SE, "Endometriosis", N Engl J Med, 360, pp.268~279 (2009)
53. Gupta S, "Pathogenic mechanisms in endometriosis-associated infertility", Fertil Steril, 90, pp.247~257 (2008)
54. Kim YA, "Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis", Gynecol Obstet Invest, 68, pp.73~81 (2009)
55. Park JS, "Endometrium from women with endometriosis shows increased proliferation activity", Fertil Steril, 92, pp.1246~1249 (2009)
56. de Ziegler D, "Endometriosis and infertility: pathophysiology and management", Lancet, 376, pp.730~738 (2010)
57. Kennedy S, "ESHRE guideline for the diagnosis and treatment of endometriosis", Hum Reprod, 20, pp.2698~2704 (2005)
58. Practice Committee of the American Society for Reproductive Medicine, "Endometriosis and infertility", Fertil Steril, 86, pp.156~160 (2006)
59. Vercellini P, "Endometriosis: current therapies and new pharmacological developments", Drugs, 69, pp.649~675 (2009)
60. Practice Committee, "Guidelines on the number of embryos transferred", Fertil Steril, 82, pp.773~774 (2004), Society for Assisted Reproductive Technology and the American Society for Reproductive Medicine
61. Sallam HN, "Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis", Cochrane Database Syst Rev, (1), pp.CD004635~ (2006)
62. Tokushige N, "Effect of progestogens and combined oral contraceptives on nerve fibers in", ~

관련 논문AI추천